Cambridge Investment Research Advisors’s Radius Health, Inc. RDUS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,387	Closed	-$224K	–	3274
2022 Q1	$224K	Hold	25,387	–	–	﹤0.01%	2789
2021 Q4	$176K	Buy	25,387 +700	+3%	+$10.3K	﹤0.01%	2929
2021 Q3	$306K	Hold	24,687	–	–	﹤0.01%	2450
2021 Q2	$450K	Hold	24,687	–	–	﹤0.01%	2139
2021 Q1	$515K	Hold	24,687	–	–	﹤0.01%	1894
2020 Q4	$441K	Hold	24,687	–	–	﹤0.01%	1855
2020 Q3	$280K	Hold	24,687	–	–	﹤0.01%	1993
2020 Q2	$336K	Hold	24,687	–	–	﹤0.01%	1796
2020 Q1	$321K	Sell	24,687 -167	-0.7%	-$2.98K	﹤0.01%	1638
2019 Q4	$501K	Buy	+24,854	New	+$604K	﹤0.01%	1576

Other funds holding RDUS

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Cambridge Investment Research Advisors's RDUS Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of Radius Health, Inc. (RDUS) in Q2 2022, closing a stake of 25,387 shares — an estimated $224K sold.

Cambridge Investment Research Advisors first reported a position in RDUS in Q4 2019 and held it in 10 quarters. The position peaked at $515K in Q1 2021. 123 funds tracked by Wall St. Rank hold RDUS as of Q2 2022.

Cambridge Investment Research Advisors reported no remaining Radius Health, Inc. position as of Q2 2022 after selling out during the quarter.
Cambridge Investment Research Advisors sold 25,387 Radius Health, Inc. shares in Q2 2022, an estimated $224K.
Cambridge Investment Research Advisors first reported a position in Radius Health, Inc. in Q4 2019 and held it in 10 quarters.
Cambridge Investment Research Advisors's Radius Health, Inc. position peaked at $515K in Q1 2021.
123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.